Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Irkutsk, Irkutsk region, Russian Federation
Irkutsk Scientific Center SB RAS (otdel mediko-biologicheskih issledovaniy i tehnologiy, glavnyy nauchnyy sotrudnik)
Irkutsk, Irkutsk region, Russian Federation
HGF is one of the factors taking part in regeneration and recovery of liver after injury. The article is dedicated to the study of influence of single HGF intake on the indices of non-specific immune response in rats after 70% liver resection in the early postoperative period. Research was conducted on 42 six-months white male Wistar rats of 250–300 g. It was revealed that level of segmentonuclear neutrophils and lymphocytes in the group with HGF intake stand at normal level on the 2nd day and normalizes to the 11th day that testifies to the decrease of inflammatory response. Increased level of leukocytes and monocytes is registered in the group with HGF intake. Also integrity of non-specific resistance in the early postoperative period on the 2nd day is registered. Suppression of phagocytosis indices with preservation of functional activity of phagocytes was registered to the 11th day.
hepatic failure, hepatocyte growth factor , non-specific resistance, inflammation
1. Frimel G (1987) (ed.) Immunological methods [Immunologicheskie metody], 383.
2. Lepekhova SА (2012). The program of standard operating procedures: laboratory animals (reception, maintenance, care and control of animal health in the vivarium of medical institution): teaching guide [Programmastandartnyh operacionnyh procedur: laboratornye zhivotnye (priem, soderzhanie, uhod i kontrol’ zdorov’ja zhivotnyh v vivarijah medicinskogo uchrezhdenija): ucheb. posobie], 96.
3. Lepekhova SА (2010). Sanogenesis of liver failure influenced by xenotransplantation of liver and spleen cells (experimental research): abstract of dissertation of Doctor of Biological Sciences [Sanogenez pechenochnoj nedostatochnosti pod vlijaniem ksenotransplantacii kletok pecheni i selezenki (jeksperimental’noe issledovanie): avtoref. … dis. d-ra biol. nauk], 47.
4. Lepekhova SА, Аpartsin KА, Zaritskaya LV, Postovaya ON, Batunova EV, Prokopjev MV, Kargin АG, Roj TА, Koval EV (2009). Effect of xenotransplantation of culture of liver cells on the changes of non-specific resistance at acute toxic liver damage [Vlijanie ksenotransplantacii kul’tury kletok pecheni na izmenenija nespecificheskoj rezistentnosti organizma pri ostrom toksicheskom povrezhdenii pecheni]. Sibirskij medicinskij zhurnal (Irkutsk), 90 (7), 101-104.
5. Litvinova LS, Kolobovnikova YV, Knutareva EN et al. (2006). Cytotoxic potential of eosinophilic granules in patients with eosinophilia syndrome [Citotoksicheskij potencial jeozinofil’nyh granul u bol’nyh s sindromom jeozinofilii]. Bjulleten’ sibirskoj mediciny, 3, 26-31.
6. Nazarenko GI (2000). Clinical evaluation of the results of laboratory tests [Klinicheskaja ocenka rezul’tatov laboratornyh issledovanij], 544.
7. Onishchenko NА, Bazieva FK (1999). Extracorporal connection of systems of bioartificial liver support in complex treatment of hepatolenticular disease [Jekstrakorporal’noe podkljuchenie sistem bioiskusstvennoj podderzhki pecheni v kompleksnom lechenii gepatocerebral’noj distrofii]. Vestnik transplantologii i iskusstvennyh organov, 1, 54-59.
8. Smirnova TL, Sergeeva VE, Sudeeva VS et al. (2010). State of immunocompetent organs in the presence of hormonal imbalance [Sostojanie immunokompetentnyh organov v uslovijah gormonal’nogo disbalansa]. Mezhdunarodnyj zhurnal po immunoreabilitacii, 12 (2), 235-236.
9. Solovjev VV (2001). Development of bioreactor for the system “biological artificial liver”: dissertation of Candidate of Biological Sciences [Razrabotka bioreaktora dlja sistemy “biologicheskaja iskusstvennaja pechen’”: dis. … kand. biol. nauk], 207.
10. Spreys IF, Аlferova MА, Mikhalevich IM, Rozhkova NY (2006). Basics of applied statistics (using Excel and Statistica in medical researches): teaching guide [Osnovy prikladnoj statistiki (ispol’zovanie Excel i Statistica v medicinskih issledovanijah): ucheb. posobie], 71.
11. Aw MM, Mitry RR, Hughes RD, Dhawan A (2007). Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. J. Pediatr. Gastroenterol. Nutr., 44 (2), 168-170.
12. Chmielowiec J, Borowiak M, Morkel M, Stradal T, Munz B, Werner S, Wehland J, Birchmeier C, Birchmeier W (2007). c-Met is essential for wound healing in the skin. J. Cell Biol., 177 (1), 151-162.
13. Dai W, Sato S, Asano G (2001). The protective effect of hepatocyte growth-promoting factor (pHGF) against carbon tetrachloride-induced acute liver injury in rats. II. Protective effects on cell membrane injury. J. Nippon Med Sch., 68 (2), 154-164.
14. Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U (2008). Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J. Cell Mol. Med., 12 (1), 56-66.
15. He Y, Zhou Y, Dou KF, Chen Y, Yan QG, Li HM (2004). Autocrine expression of hepatocyte growth factor and its cytoprotective effect on hepatocyte poisoning. World J. Gastroenterol., 10 (19), 2827-2830.
16. Koch KS, Leffert HL (1979). Increased sodium ion influx in necessary to initiate rat hepatocyte proliferation. Cell, 12 (12), 821-832.
17. Li Z, Mizuno S, Nakamura T (2007). Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am. J. Physiol. Gastrointest. Liver Physiol., 292, 639-646.
18. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH. Primary culture of cryopreserved human hepatocytes on homologous extracellular matrix and the influence of monocytic products on albumin secretion. J. Hepatol., 7, 34-44.
19. Ogura Y, Hamanoue M, Tanabe G, Mitsue S, Yoshidome S, Nuruki K, Aikou T (2001). Hepatocyte growth factor promotes liver regeneration and protein synthesis after hepatectomy in cirrhotic rats. Hepatogastroenterology, 48 (38), 545-549.
20. Otsuka T, Takagi H, Horiguchi N, Toyoda M, Sato K, Takayama H, Mori M (2002). CCl4-induced acute liver injury in mice is inhibited by hepatocyte growth factor overexpression but stimulated by NK2 overexpression. FEBS Lett., 532 (3), 391-395.
21. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK (2001). The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology, 34 (4), 688-693.
22. Sato S, Dai W, Liu XL, Asano G (1999). The protective effect of hepatocyte growth-promoting factor (pHGF) against carbon tetrachloride-induced acute liver injury in rats: an ultrastructural study. Med. Electron. Microsc., 32 (3), 184-192.
23. Tomiya T, Ogata I, Fujiwara K (1998). Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am. J. Pathol., 153 (3), 955-961.
24. Tomiya T, Omata M, Imamura H, Fujiwara K (2008). Impaired liver regeneration in acute liver failure: the significance of cross-communication of growth associated factors in liver regeneration. Hepatol. Res., 38, 29-S33.
25. Weber A, Groyer-Picard MT, Franco D, Dagher I (2009). Hepatocyte transplantation in animal models. Liver Transpl., 15 (1), 7-14.
26. Yu C, Wang F, Jin C, Huang X, Miller DL, Basilico C, McKeehan WL (2003). Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am. J. Pathol., 163, 1653-1662.
